Protease-Activated Receptor 1 as Therapeutic Target in Breast, Lung, and Ovarian Cancer: Pepducin Approach
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Protease-Activated Receptor 1 as Therapeutic Target in Breast, Lung, and Ovarian Cancer: Pepducin Approach
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 19, Issue 8, Pages 2237
Publisher
MDPI AG
Online
2018-08-01
DOI
10.3390/ijms19082237
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Noncanonical Matrix Metalloprotease 1–Protease-Activated Receptor 1 Signaling Drives Progression of AtherosclerosisHighlights
- (2018) Rajashree Rana et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- The α-arrestin ARRDC3 suppresses breast carcinoma invasion by regulating G protein–coupled receptor lysosomal sorting and signaling
- (2018) Aleena K. S. Arakaki et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- TGF-β induced PAR-1 expression promotes tumor progression and osteoclast differentiation in giant cell tumor of bone
- (2017) Ting Wang et al. INTERNATIONAL JOURNAL OF CANCER
- Magnetic Fields and Reactive Oxygen Species
- (2017) Huizhen Wang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- ALEX1, a novel tumor suppressor gene, inhibits gastric cancer metastasis via the PAR-1/Rho GTPase signaling pathway
- (2017) Li Pang et al. JOURNAL OF GASTROENTEROLOGY
- Doxycycline inhibits breast cancer EMT and metastasis through PAR-1/NF-κB/miR-17/E-cadherin pathway
- (2017) Weilong Zhong et al. Oncotarget
- The Role of Na+/Ca2+ Exchanger 1 in Maintaining Ductus Arteriosus Patency
- (2017) Minghui Li et al. Scientific Reports
- Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial
- (2016) Marco Valgimigli et al. EUROPEAN HEART JOURNAL
- Twist-mediated Epithelial-mesenchymal Transition Promotes Breast Tumor Cell Invasion via Inhibition of Hippo Pathway
- (2016) Yifan Wang et al. Scientific Reports
- Cell-Penetrating Pepducin Therapy Targeting PAR1 in Subjects With Coronary Artery Disease
- (2015) Paul A. Gurbel et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- G-Protein–Coupled Receptors Signaling Pathways in New Antiplatelet Drug DevelopmentSignificance
- (2015) Paul A. Gurbel et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Colon Cancer Growth and Dissemination Relies upon Thrombin, Stromal PAR-1, and Fibrinogen
- (2015) G. N. Adams et al. CANCER RESEARCH
- Allosteric Activation of a G Protein-coupled Receptor with Cell-penetrating Receptor Mimetics
- (2015) Ping Zhang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Endothelial Angiogenesis and Barrier Function in Response to Thrombin Require Ca2+Influx through the Na+/Ca2+Exchanger
- (2015) Petros Andrikopoulos et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- IMP-3 Promotes Migration and Invasion of Melanoma Cells by Modulating the Expression of HMGA2 and Predicts Poor Prognosis in Melanoma
- (2015) Yi-Shuan Sheen et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Host and tumor derived MMP13 regulate extravasation and establishment of colorectal metastases in the liver
- (2015) Alisha M Mendonsa et al. Molecular Cancer
- Dysregulated protease activated receptor 1 (PAR1) promotes metastatic phenotype in breast cancer through HMGA2
- (2015) E Yang et al. ONCOGENE
- PH motifs in PAR1&2 endow breast cancer growth
- (2015) A. Kancharla et al. Nature Communications
- Matrix metalloproteinase 1 and circulating tumor cells in early breast cancer
- (2014) Zuzana Cierna et al. BMC CANCER
- Cell-Surface Receptors Transactivation Mediated by G Protein-Coupled Receptors
- (2014) Fabio Cattaneo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Ras-related Protein, Rap1A, Mediates Thrombin-stimulated, Integrin-dependent Glioblastoma Cell Proliferation and Tumor Growth
- (2014) Jacqueline Sayyah et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- -Arrestins - new players in Notch and GPCR signaling pathways in mammals
- (2014) L. Puca et al. JOURNAL OF CELL SCIENCE
- Mouse Matrix Metalloprotease-1a (Mmp1a) Gives New Insight Into MMP Function
- (2014) Caitlin J. Foley et al. JOURNAL OF CELLULAR PHYSIOLOGY
- MUC1-C Induces the LIN28B→LET-7→HMGA2 Axis to Regulate Self-Renewal in NSCLC
- (2014) Maroof Alam et al. MOLECULAR CANCER RESEARCH
- Molecular mechanisms of epithelial–mesenchymal transition
- (2014) Samy Lamouille et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Presentation and management of docetaxel-related adverse effects in patients with breast cancer
- (2014) Maria Ho et al. Cancer Management and Research
- Biased Signaling of Protease-Activated Receptors
- (2014) Peishen Zhao et al. Frontiers in Endocrinology
- Tumor MMP-1 Activates Endothelial PAR1 to Facilitate Vascular Intravasation and Metastatic Dissemination
- (2013) A. Juncker-Jensen et al. CANCER RESEARCH
- Matrix Metalloproteinase Mmp-1a Is Dispensable for Normal Growth and Fertility in Mice and Promotes Lung Cancer Progression by Modulating Inflammatory Responses
- (2013) Miriam Fanjul-Fernández et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Noncanonical Matrix Metalloprotease-1-Protease-activated Receptor-1 Signaling Triggers Vascular Smooth Muscle Cell Dedifferentiation and Arterial Stenosis
- (2013) Karyn M. Austin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- HMGA2 functions as a competing endogenous RNA to promote lung cancer progression
- (2013) Madhu S. Kumar et al. NATURE
- Matrix metalloprotease 1a deficiency suppresses tumor growth and angiogenesis
- (2013) C J Foley et al. ONCOGENE
- Biased agonism of protease-activated receptor 1 by activated protein C caused by noncanonical cleavage at Arg46
- (2012) L. O. Mosnier et al. BLOOD
- Matrix metalloproteases and PAR1 activation
- (2012) K. M. Austin et al. BLOOD
- Suppression of Arterial Thrombosis Without Affecting Hemostatic Parameters With a Cell-Penetrating PAR1 Pepducin
- (2012) Ping Zhang et al. CIRCULATION
- β-Adrenergic Receptor Stimulation Transactivates Protease-Activated Receptor 1 via Matrix Metalloproteinase 13 in Cardiac Cells
- (2012) Fabrice Jaffré et al. CIRCULATION
- Novel oral anticoagulants in acute coronary syndrome
- (2012) Charis Costopoulos et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Turning Receptors On and Off with Intracellular Pepducins: New Insights into G-protein-coupled Receptor Drug Development
- (2012) Katie O'Callaghan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Matrix Metalloprotease-1a Promotes Tumorigenesis and Metastasis
- (2012) Caitlin J. Foley et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Atopaxar and its effects on markers of platelet activation and inflammation: results from the LANCELOT CAD program
- (2012) Michelle L. O’Donoghue et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- High-resolution crystal structure of human protease-activated receptor 1
- (2012) Cheng Zhang et al. NATURE
- Vorapaxar in the Secondary Prevention of Atherothrombotic Events
- (2012) David A. Morrow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting Protease-Activated Receptor-1 with Cell-Penetrating Pepducins in Lung Cancer
- (2011) Jaroslaw Cisowski et al. AMERICAN JOURNAL OF PATHOLOGY
- G protein-coupled receptor modulation with pepducins: moving closer to the clinic
- (2011) Patricia Dimond et al. Annals of the New York Academy of Sciences
- Targeting CXCR4 with cell-penetrating pepducins in lymphoma and lymphocytic leukemia
- (2011) K. O'Callaghan et al. BLOOD
- Randomized Trial of Atopaxar in the Treatment of Patients With Coronary Artery Disease
- (2011) Stephen D. Wiviott et al. CIRCULATION
- Safety and Tolerability of Atopaxar in the Treatment of Patients With Acute Coronary Syndromes
- (2011) Michelle L. O'Donoghue et al. CIRCULATION
- A matrix metalloprotease-PAR1 system regulates vascular integrity, systemic inflammation and death in sepsis
- (2011) Sarah L. Tressel et al. EMBO Molecular Medicine
- Direct Interaction between an Allosteric Agonist Pepducin and the Chemokine Receptor CXCR4
- (2011) Jay M. Janz et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
- (2011) Pierluigi Tricoci et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interdicting protease-activated receptor-2-driven inflammation with cell-penetrating pepducins
- (2011) L. M. Sevigny et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tumor Progression Locus 2 Mediates Signal-Induced Increases in Cytoplasmic Calcium and Cell Migration
- (2011) M. Hatziapostolou et al. Science Signaling
- Identification of a Metalloprotease-Chemokine Signaling System in the Ovarian Cancer Microenvironment: Implications for Antiangiogenic Therapy
- (2010) A. Agarwal et al. CANCER RESEARCH
- Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
- (2010) Kai Kessenbrock et al. CELL
- Discovery of a CXCR4 agonist pepducin that mobilizes bone marrow hematopoietic cells
- (2010) B. Tchernychev et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Insider access: pepducin symposium explores a new approach to GPCR modulation
- (2009) Jacquelyn Miller et al. Annals of the New York Academy of Sciences
- Blockade of PAR1 Signaling with Cell-Penetrating Pepducins Inhibits Akt Survival Pathways in Breast Cancer Cells and Suppresses Tumor Survival and Metastasis
- (2009) E. Yang et al. CANCER RESEARCH
- Platelet Matrix Metalloprotease-1 Mediates Thrombogenesis by Activating PAR1 at a Cryptic Ligand Site
- (2009) Vishal Trivedi et al. CELL
- PAR1 is selectively over expressed in high grade breast cancer patients: a cohort study
- (2009) Norma A Hernández et al. Journal of Translational Medicine
- Irreversible Platelet Activation Requires Protease-Activated Receptor 1-Mediated Signaling to Phosphatidylinositol Phosphates
- (2009) M. Holinstat et al. MOLECULAR PHARMACOLOGY
- HMGA2 and Smads Co-regulate SNAIL1 Expression during Induction of Epithelial-to-Mesenchymal Transition
- (2008) Sylvie Thuault et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Targeting a metalloprotease-PAR1 signaling system with cell-penetrating pepducins inhibits angiogenesis, ascites, and progression of ovarian cancer
- (2008) A. Agarwal et al. MOLECULAR CANCER THERAPEUTICS
- Persistent transactivation of EGFR and ErbB2/HER2 by protease-activated receptor-1 promotes breast carcinoma cell invasion
- (2008) P Arora et al. ONCOGENE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started